Koru BioTech is a New Zealand biotechnology company building on breakthrough research into infection biology to develop new approaches to diagnostics, prevention, and immune protection.

Our work began with research into infectious diseases in dairy cattle, where we identified three important scientific insights:
•	A measurable biomarker linked to Gram-negative infections
•	A non antibiotic approach to treat Gram negative pathogens
•	A naturally occurring immune complex that helps protect newborns from disease.

As our research has progressed, so has our understanding of where it can lead. Today, Koru is building on this foundation to explore new approaches across a wider range of infectious disease settings.

With peer-reviewed research, protected intellectual property, and ongoing development work, the company is focused on translating scientific insight into practical tools that improve outcomes while supporting more responsible use of antibiotics.

Koru works at the intersection of infection biology, diagnostics, and prevention, with potential relevance across animal health, agriculture, and broader One Health contexts.

We aim to turn deeper understanding of infection biology into tools that improve outcomes and reduce reliance on broad antibiotic use.


Koru Biotech

Org chart

Teams

Offices

Koru Biotech

Org chart

Teams

Offices

Related companies